Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF OPERATIONS

v3.8.0.1
CONDENSED STATEMENT OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Operating expenses:        
Research and development $ 2,000 $ 183 $ 2,580 $ 1,168
General and administration 848 200 2,516 693
Loss from operations (2,848) (383) (5,096) (1,861)
Interest income (6) 0 (6) 0
Interest expense 106 89 294 261
Interest expense - related party 0 53 81 132
Change in fair value of convertible notes payable 0 0 99 0
Change in fair value of warrant liabilities 0 19 451 108
Net Loss $ (2,948) $ (544) $ (6,015) $ (2,362)
Net loss per common share outstanding, basic and diluted $ (0.30) $ (0.19) $ (1.09) $ (0.85)
Weighted average number of common shares outstanding, basic and diluted 9,972,663 2,848,651 5,514,988 2,790,674